Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
View: Text | PDF
Research Article Gastroenterology Inflammation

KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model

  • Text
  • PDF
Abstract

Inflammatory bowel disease (IBD) is a chronic illness characterized by dysregulated immune cascades in the intestines, in which the Th17 immune response plays an important role. We demonstrated that mice with intestinal epithelium–specific deletion of Krüppel-like factor 5 (Klf5) developed Th17-dependent colonic inflammation. In the absence of KLF5, there was aberrant cellular localization of phosphorylated STAT3, an essential mediator of the Th17-associated cytokine, IL-22, which is required for epithelial tissue regeneration. In contrast, mitigation of IL-17A with anti–IL-17A neutralizing antibody attenuated colitis in Klf5-deficient mice. There was also a considerable shift in the colonic microbiota of Klf5-deficient mice that phenocopied human IBD. Notably, the inflammatory response due to Klf5 deletion was alleviated by antibiotic treatment, implicating the role of microbiota in pathogenesis. Finally, human colitic tissues had reduced KLF5 levels when compared with healthy tissues. Together, these findings demonstrated the importance of KLF5 in protecting the intestinal epithelium against Th17-mediated immune and inflammatory responses. The mice described herein may serve as a potential model for human IBD.

Authors

Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang

×

Figure 7

Knockdown of KLF5 does not induce phosphorylation of STAT3 but affects the localization of p-STAT3 in response to IL-22 stimulation.

Options: View larger image (or click on image) Download as PowerPoint
Knockdown of KLF5 does not induce phosphorylation of STAT3 but affects t...
(A) Western blots of C2BBECtrl and C2BBEΔIND cells treated with a combination of DMSO or DOX and PBS or IL-22 (n = 3). (B) Quantification of KLF5 normalized with GAPDH (n = 3). (C) Quantifications of adjusted p-STAT3 protein level over the adjusted STAT3 protein level. Adjustments were normalized with GAPDH for both markers (n = 3). (D) Western blots of cytoplasmic-nuclear fractionation assays. The top blot represents the nuclear fractions and the bottom represents the cytosolic fractions. (E and F) Quantifications for KLF5 normalized to H3 in the nuclear fraction (E) and for KLF5 normalized to GAPDH in the cytosolic fraction (F) (n = 3). (G) Quantification of p-STAT3 protein normalized to H3 in the nuclear fraction (n = 3). (H) Quantification of p-STAT3 level adjusted to GAPDH to adjusted total STAT3 levels in the cytosolic fraction (n = 3). (I) STAT3, p-STAT3, and DAPI immunofluorescence staining of C2BBEΔIND cells treated with DMSO/DOX and PBS/IL-22. (J) Co-IP of p-STAT3 and endogenous (left panel) or overexpressed KLF5 (right panel). Data from graphs represent mean ± SEM. *P < 0.05; ***P < 0.001; 1-way ANOVA. Scale bars: 70 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts